Literature DB >> 11030662

The practical management of claudication.

A Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11030662      PMCID： PMC1118719          DOI： 10.1136/bmj.321.7266.911

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study.

Authors:  G D Smith; M J Shipley; G Rose
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

Review 2.  Lower-limb arterial disease.

Authors:  J Golledge
Journal:  Lancet       Date:  1997-11-15       Impact factor: 79.321

3.  Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response?

Authors:  P V Tisi; M Hulse; A Chulakadabba; P Gosling; C P Shearman
Journal:  Eur J Vasc Endovasc Surg       Date:  1997-11       Impact factor: 7.069

4.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

5.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

6.  The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia.

Authors:  I Smith; P J Franks; R M Greenhalgh; N R Poulter; J T Powell
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-05       Impact factor: 7.069

7.  Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease.

Authors: 
Journal:  Arch Intern Med       Date:  1994-05-09

8.  Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality.

Authors:  T Jonason; R Bergström
Journal:  Acta Med Scand       Date:  1987

9.  Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease.

Authors:  F B Smith; G D Lowe; F G Fowkes; A Rumley; A G Rumley; P T Donnan; E Housley
Journal:  Atherosclerosis       Date:  1993-09       Impact factor: 5.162

10.  Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

Authors:  A W Gardner; E T Poehlman
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272
View more
  3 in total

1.  Secondary prevention may help intermittent claudication.

Authors:  A Vass; G Leng; O Papacosta; M Walker; L Lennon; P H Whincup
Journal:  BMJ       Date:  2001-03-17

2.  Exercise for intermittent claudication. Supervised programmes should be universally available.

Authors:  A H Stewart; P M Lamont
Journal:  BMJ       Date:  2001-09-29

Review 3.  Critical limb ischemia: advanced medical therapy.

Authors:  Mark G Davies
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.